Alliance Pharma PLC
LSE:APH
Wall Street
Price Targets
APH Price Targets Summary
Alliance Pharma PLC
According to Wall Street analysts, the average 1-year price target for APH is 67.61 GBX with a low forecast of 62.62 GBX and a high forecast of 89.25 GBX.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is APH's stock price target?
Price Target
67.61
GBX
According to Wall Street analysts, the average 1-year price target for APH is 67.61 GBX with a low forecast of 62.62 GBX and a high forecast of 89.25 GBX.
What is Alliance Pharma PLC's Revenue forecast?
Projected CAGR
9%
For the last 8 years the compound annual growth rate for Alliance Pharma PLC's revenue is 8%. The projected CAGR for the next 3 years is 9%.
What is Alliance Pharma PLC's Operating Income forecast?
Projected CAGR
16%
For the last 8 years the compound annual growth rate for Alliance Pharma PLC's operating income is 4%. The projected CAGR for the next 3 years is 16%.
You don't have any saved screeners yet
